Browsing by Author "Georgiev, Dejan (36542322400)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication A multicenter study of genetic testing for Parkinson’s disease in the clinical setting(2022) ;Kovanda, Anja (26321108500) ;Rački, Valentino (57118308400) ;Bergant, Gaber (57200649043) ;Georgiev, Dejan (36542322400) ;Flisar, Dušan (6503981050) ;Papić, Eliša (57222495640) ;Brankovic, Marija (58122593400) ;Jankovic, Milena (54881096000) ;Svetel, Marina (6701477867) ;Teran, Nataša (6603505590) ;Maver, Aleš (22135394900) ;Kostic, Vladimir S. (35239923400) ;Novakovic, Ivana (6603235567) ;Pirtošek, Zvezdan (6603412901) ;Rakuša, Martin (12792397700) ;Vuletić, Vladimira (57223931740)Peterlin, Borut (55816646000)Parkinson’s disease (PD) guidelines lack clear criteria for genetic evaluation. We assessed the yield and rationale of genetic testing for PD in a routine clinical setting on a multicenter cohort of 149 early-onset and familial patients by exome sequencing and semi-quantitative multiplex ligation-dependent probe amplification of evidence-based PD-associated gene panel. We show that genetic testing for PD should be considered for both early-onset and familial patients alike, and a clinical yield of about 10% in the Caucasian population can be expected. © 2022, The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication A multicenter study of genetic testing for Parkinson’s disease in the clinical setting(2022) ;Kovanda, Anja (26321108500) ;Rački, Valentino (57118308400) ;Bergant, Gaber (57200649043) ;Georgiev, Dejan (36542322400) ;Flisar, Dušan (6503981050) ;Papić, Eliša (57222495640) ;Brankovic, Marija (58122593400) ;Jankovic, Milena (54881096000) ;Svetel, Marina (6701477867) ;Teran, Nataša (6603505590) ;Maver, Aleš (22135394900) ;Kostic, Vladimir S. (35239923400) ;Novakovic, Ivana (6603235567) ;Pirtošek, Zvezdan (6603412901) ;Rakuša, Martin (12792397700) ;Vuletić, Vladimira (57223931740)Peterlin, Borut (55816646000)Parkinson’s disease (PD) guidelines lack clear criteria for genetic evaluation. We assessed the yield and rationale of genetic testing for PD in a routine clinical setting on a multicenter cohort of 149 early-onset and familial patients by exome sequencing and semi-quantitative multiplex ligation-dependent probe amplification of evidence-based PD-associated gene panel. We show that genetic testing for PD should be considered for both early-onset and familial patients alike, and a clinical yield of about 10% in the Caucasian population can be expected. © 2022, The Author(s).
